Ad is loading...
INZY
Price
$2.69
Change
-$0.10 (-3.58%)
Updated
Nov 21 closing price
118 days until earnings call
PRAX
Price
$73.06
Change
-$0.62 (-0.84%)
Updated
Nov 21 closing price
110 days until earnings call
Ad is loading...

INZY vs PRAX

Header iconINZY vs PRAX Comparison
Open Charts INZY vs PRAXBanner chart's image
Inozyme Pharma
Price$2.69
Change-$0.10 (-3.58%)
Volume$371.49K
CapitalizationN/A
Praxis Precision Medicines
Price$73.06
Change-$0.62 (-0.84%)
Volume$307.26K
CapitalizationN/A
INZY vs PRAX Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
INZY vs. PRAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Buy and PRAX is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (INZY: $2.69 vs. PRAX: $73.06)
Brand notoriety: INZY and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 138% vs. PRAX: 100%
Market capitalization -- INZY: $179.23M vs. PRAX: $1.37B
INZY [@Biotechnology] is valued at $179.23M. PRAX’s [@Biotechnology] market capitalization is $1.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 1 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 1 green, 4 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, both INZY and PRAX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while PRAX’s TA Score has 2 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 7 bearish.
  • PRAX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, INZY is a better buy in the short-term than PRAX.

Price Growth

INZY (@Biotechnology) experienced а -21.57% price change this week, while PRAX (@Biotechnology) price change was -4.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

INZY is expected to report earnings on Mar 20, 2025.

PRAX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($1.37B) has a higher market cap than INZY($179M). PRAX YTD gains are higher at: 227.917 vs. INZY (-36.854). INZY has higher annual earnings (EBITDA): -90.3M vs. PRAX (-163.59M). PRAX has more cash in the bank: 357M vs. INZY (132M). PRAX has less debt than INZY: PRAX (1.66M) vs INZY (46.8M). PRAX has higher revenues than INZY: PRAX (1.61M) vs INZY (0).
INZYPRAXINZY / PRAX
Capitalization179M1.37B13%
EBITDA-90.3M-163.59M55%
Gain YTD-36.854227.917-16%
P/E RatioN/AN/A-
Revenue01.61M-
Total Cash132M357M37%
Total Debt46.8M1.66M2,819%
TECHNICAL ANALYSIS
Technical Analysis
INZYPRAX
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 19 days ago
86%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OBGIX31.470.37
+1.19%
Oberweis Global Opportunities Instl
VAFAX30.420.22
+0.73%
Invesco American Franchise A
WPSGX60.450.42
+0.70%
AB Concentrated Growth Advisor
AIECX19.360.08
+0.41%
Invesco EQV International Equity C
JACRX13.790.05
+0.36%
Easterly Global Real Estate C

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-3.58%
BEAM - INZY
56%
Loosely correlated
-3.72%
FATE - INZY
49%
Loosely correlated
-6.76%
ABOS - INZY
49%
Loosely correlated
-2.53%
DNLI - INZY
49%
Loosely correlated
-0.82%
PGEN - INZY
48%
Loosely correlated
+7.91%
More

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with VERU. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then VERU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
-0.84%
VERU - PRAX
35%
Loosely correlated
+0.42%
INZY - PRAX
34%
Loosely correlated
-3.58%
ZYME - PRAX
33%
Loosely correlated
-5.98%
CLRB - PRAX
33%
Loosely correlated
+1.28%
CYTK - PRAX
32%
Poorly correlated
-4.39%
More